Quality of Life for 19,114 participants in the ASPREE (ASPirin in Reducing Events in the Elderly) study and their association with sociodemographic and modifiable lifestyle risk factors
Purpose: To explore the relationship between sociodemographic and lifestyle variables with health-related quality of life (HRQoL) of a large cohort of ‘healthy’ older individuals. Methods: The sample included individuals aged 65+ years from Australia (N = 16,703) and the USA (N = 2411) enrolled in t...
| Main Authors: | Stocks, N., González-Chica, D., Woods, R., Lockery, J., Wolfe, R., Murray, A., Kirpach, B., Shah, R., Nelson, M., Reid, Christopher, Ernst, M., McNeil, J. |
|---|---|
| Format: | Journal Article |
| Published: |
Springer
2018
|
| Online Access: | http://hdl.handle.net/20.500.11937/74225 |
Similar Items
ASPREE-D: Aspirin for the prevention of depression in the elderly
by: Berk, M., et al.
Published: (2016)
by: Berk, M., et al.
Published: (2016)
Baseline Characteristics of Participants in the ASPREE (Aspirin in Reducing Events in the Elderly) Study
by: McNeil, J., et al.
Published: (2019)
by: McNeil, J., et al.
Published: (2019)
Baseline Characteristics of Participants in the ASPREE (ASPirin in Reducing Events in the Elderly) Study
by: McNeil, J., et al.
Published: (2017)
by: McNeil, J., et al.
Published: (2017)
Prevalence of chronic kidney disease in the elderly using the ASPirin in Reducing Events in the Elderly (ASPREE) study cohort
by: Polkinghorne, K., et al.
Published: (2019)
by: Polkinghorne, K., et al.
Published: (2019)
Age-related macular degeneration in a randomized controlled trial of low-dose aspirin: Rationale and study design of the ASPREE-AMD study
by: Robman, L., et al.
Published: (2017)
by: Robman, L., et al.
Published: (2017)
Overcoming challenges to data quality in the ASPREE clinical trial
by: Lockery, J.E., et al.
Published: (2019)
by: Lockery, J.E., et al.
Published: (2019)
The aspirin in reducing events in the elderly trial: Statistical analysis plan
by: Wolfe, R., et al.
Published: (2018)
by: Wolfe, R., et al.
Published: (2018)
Slowing the progression of age-related hearing loss: Rationale and study design of the ASPIRIN in HEARING, retinal vessels imaging and neurocognition in older generations (ASPREE-HEARING) trial
by: Lowthian, J., et al.
Published: (2016)
by: Lowthian, J., et al.
Published: (2016)
Study design of ASPirin in Reducing Events in the Elderly (ASPREE): A randomized, controlled trial
by: Grimm, R., et al.
Published: (2013)
by: Grimm, R., et al.
Published: (2013)
Effect of aspirin on disability-free survival in the healthy elderly
by: McNeil, J., et al.
Published: (2018)
by: McNeil, J., et al.
Published: (2018)
Effect of aspirin on all-cause mortality in the healthy elderly
by: McNeil, J., et al.
Published: (2018)
by: McNeil, J., et al.
Published: (2018)
Effect of aspirin on cardiovascular events and bleeding in the healthy elderly
by: McNeil, J., et al.
Published: (2018)
by: McNeil, J., et al.
Published: (2018)
A multistate model of health transitions in older people: a secondary analysis of ASPREE clinical trial data
by: Neumann, J.T., et al.
Published: (2022)
by: Neumann, J.T., et al.
Published: (2022)
Randomized placebo-controlled trial of the effects of aspirin on dementia and cognitive decline.
by: Ryan, Joanne, et al.
Published: (2020)
by: Ryan, Joanne, et al.
Published: (2020)
Effect of Aspirin vs Placebo on the Prevention of Depression in Older People: A Randomized Clinical Trial
by: Berk, M., et al.
Published: (2020)
by: Berk, M., et al.
Published: (2020)
Associations between blood sex steroid concentrations and risk of major adverse cardiovascular events in healthy older women in Australia: a prospective cohort substudy of the ASPREE trial
by: Islam, R.M., et al.
Published: (2022)
by: Islam, R.M., et al.
Published: (2022)
Effect of aspirin on cancer incidence and mortality in older adults.
by: McNeil, John J, et al.
Published: (2020)
by: McNeil, John J, et al.
Published: (2020)
Genetic variation in PEAR1, cardiovascular outcomes and effects of aspirin in a healthy elderly population
by: Lewis, J.P., et al.
Published: (2020)
by: Lewis, J.P., et al.
Published: (2020)
Sociodemographic, lifestyle and health determinants of suicidal behaviour in Malaysia
by: Cheah, Yong Kang, et al.
Published: (2018)
by: Cheah, Yong Kang, et al.
Published: (2018)
Patient-reported GP health assessments rather than individual cardiovascular risk burden are associated with the engagement in lifestyle changes: Population-based survey in South Australia
by: Gonzalez-Chica, D.A., et al.
Published: (2019)
by: Gonzalez-Chica, D.A., et al.
Published: (2019)
The Study of Neurocognitive Outcomes, Radiological and Retinal Effects of Aspirin in Sleep Apnoea- rationale and methodology of the SNORE-ASA study
by: Ward, S., et al.
Published: (2018)
by: Ward, S., et al.
Published: (2018)
Normative performance of healthy older individuals on the Modified Mini-Mental State (3MS) examination according to ethno-racial group, gender, age, and education level
by: Ryan, J., et al.
Published: (2018)
by: Ryan, J., et al.
Published: (2018)
Psychometric properties of a short form of the Center for Epidemiologic Studies Depression (CES-D-10) scale for screening depressive symptoms in healthy community dwelling older adults
by: Mohebbi, M., et al.
Published: (2017)
by: Mohebbi, M., et al.
Published: (2017)
Sociodemographic, lifestyle, and health factors associated with depression among adults in Malaysia: an ethnic comparison
by: Cheah, Yong Kang, et al.
Published: (2019)
by: Cheah, Yong Kang, et al.
Published: (2019)
Sociodemographic, lifestyle, and health factors associated with depression and generalized anxiety disorder among Malaysian adults
by: Cheah, Yong Kang, et al.
Published: (2020)
by: Cheah, Yong Kang, et al.
Published: (2020)
Twisted Aspirin Crystals
by: Cui, X., et al.
Published: (2013)
by: Cui, X., et al.
Published: (2013)
Age, gender and sociodemographic differences in school entrants' social and emotional competence
by: Nelson, Helen
Published: (2012)
by: Nelson, Helen
Published: (2012)
Association of Statin Use With Disability-Free Survival and Cardiovascular Disease Among Healthy Older Adults
by: Zhou, Z., et al.
Published: (2020)
by: Zhou, Z., et al.
Published: (2020)
Simple Synthetic Receptors for Aspirin
by: Nguyen, Thanh Vinh, et al.
Published: (2014)
by: Nguyen, Thanh Vinh, et al.
Published: (2014)
Aspirin for the prevention of cognitive decline in the elderly: Rationale and design of a neuro-vascular imaging study (ENVIS-ion)
by: Reid, Christopher, et al.
Published: (2012)
by: Reid, Christopher, et al.
Published: (2012)
Dipyridamole plus aspirin versus aspirin alone in the secondary prevention after TIA or stroke: a meta-analysis by risk
by: Halkes, P.H.A., et al.
Published: (2008)
by: Halkes, P.H.A., et al.
Published: (2008)
Sociodemographic and medical risk factors associated with antepartum depression
by: Babu, Giridhara R., et al.
Published: (2018)
by: Babu, Giridhara R., et al.
Published: (2018)
Randomized factorial trial of esomeprazole and aspirin in Barrett’s oesophagus: the Aspirin and Esomeprazole Chemoprevention in Barrett’s metaplasia Trial (AspECT)
by: Jankowski, Janusz A.Z., et al.
Published: (2018)
by: Jankowski, Janusz A.Z., et al.
Published: (2018)
Impact of the 2017 AmericanHeart Association and American College of Cardiology hypertension guideline in aged individuals
by: Chowdhury, Enayet, et al.
Published: (2020)
by: Chowdhury, Enayet, et al.
Published: (2020)
Selective binding and release of aspirin by an encapsulating receptor
by: Nguyen, Thanh Vinh, et al.
Published: (2010)
by: Nguyen, Thanh Vinh, et al.
Published: (2010)
Synthesis and Antibacterial Study of Aspirin-Chalcone Derivatives
by: Zainab, Ngaini, et al.
Published: (2013)
by: Zainab, Ngaini, et al.
Published: (2013)
Synthesis of aspirin-chalcone derivatives and their antibacterial activity
by: Lim, Ji Yuan
Published: (2015)
by: Lim, Ji Yuan
Published: (2015)
Optimising medication data collection in a large-scale clinical trial
by: Lockery, J.E., et al.
Published: (2019)
by: Lockery, J.E., et al.
Published: (2019)
Sociodemographic predictors of latent class membership of problematic and disordered gamblers
by: James, Richard J.E., et al.
Published: (2016)
by: James, Richard J.E., et al.
Published: (2016)
Cost-effectiveness of low-dose rivaroxaban and aspirin versus aspirin alone in people with peripheral or carotid artery disease: An Australian healthcare perspective
by: Zomer, E., et al.
Published: (2018)
by: Zomer, E., et al.
Published: (2018)
Similar Items
-
ASPREE-D: Aspirin for the prevention of depression in the elderly
by: Berk, M., et al.
Published: (2016) -
Baseline Characteristics of Participants in the ASPREE (Aspirin in Reducing Events in the Elderly) Study
by: McNeil, J., et al.
Published: (2019) -
Baseline Characteristics of Participants in the ASPREE (ASPirin in Reducing Events in the Elderly) Study
by: McNeil, J., et al.
Published: (2017) -
Prevalence of chronic kidney disease in the elderly using the ASPirin in Reducing Events in the Elderly (ASPREE) study cohort
by: Polkinghorne, K., et al.
Published: (2019) -
Age-related macular degeneration in a randomized controlled trial of low-dose aspirin: Rationale and study design of the ASPREE-AMD study
by: Robman, L., et al.
Published: (2017)